3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Cisplatin
14
pembrolizumab
8
Radiotherapy
7
Nivolumab
7
Radiotherapy, Intensity-Modulated
5
Cetuximab
5
Carboplatin
5
Fluorouracil
4
durvalumab
3
Radiosurgery
3
Magnetic Resonance Spectroscopy
3
Docetaxel
3
fluoromisonidazole
2
epacadostat
2
Standard of Care
2
Specimen Handling
2
Photochemotherapy
2
Paclitaxel
2
Drug Therapy
2
Cyclophosphamide
2
Chemotherapy, Adjuvant
2
Capecitabine
2
C188-9 compound
2
zimberelimab
1
yeast-CEA vaccine
1
vandetanib
1
temoporfin
1
talazoparib
1
ruxolitinib
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Squamous Cell Carcinoma of Head and Neck
×
mocetinostat
×
Clear all
NCT02993991
2017-12-29
PRIMED-001
University Health Network, Toronto
Phase 1
Withdrawn